Rocket Pharmaceuticals, Inc.

NasdaqGM:RCKT 주식 보고서

시가총액: US$1.9b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Rocket Pharmaceuticals 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

NasdaqGM:RCKT 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
16 May 24SellUS$24,471Martin WilsonIndividual1,048US$23.35
16 May 24SellUS$25,195John MilitelloIndividual1,079US$23.35
16 May 24SellUS$94,474Kinnari PatelIndividual4,046US$23.35
16 May 24SellUS$228,597Gaurav ShahIndividual9,790US$23.35
22 Apr 24SellUS$19,051John MilitelloIndividual833US$22.87
15 Apr 24SellUS$240,520David SouthwellIndividual10,000US$24.05
08 Apr 24SellUS$308,763Mark WhiteIndividual12,532US$24.64
21 Mar 24SellUS$69,979John MilitelloIndividual2,490US$28.10
21 Mar 24SellUS$7,790,943Simran Investment Group LlcCompany274,000US$28.43
29 Feb 24SellUS$120,257Martin WilsonIndividual4,100US$29.33
16 Feb 24SellUS$604,876Gaurav ShahIndividual20,272US$29.84
16 Feb 24SellUS$96,615John MilitelloIndividual3,238US$29.84
16 Feb 24SellUS$106,701Martin WilsonIndividual3,576US$29.84
16 Feb 24SellUS$212,805Kinnari PatelIndividual7,132US$29.84
22 Jan 24SellUS$17,356John MilitelloIndividual638US$27.20
15 Nov 23SellUS$450,646Simran Investment Group LlcCompany20,000US$22.53
20 Oct 23SellUS$9,623John MilitelloIndividual564US$17.06
29 Sep 23SellUS$315,744Simran Investment Group LlcCompany14,989US$21.14
17 Aug 23SellUS$73,750Gaurav ShahIndividual4,767US$15.47
17 Aug 23SellUS$4,394John MilitelloIndividual284US$15.47
17 Aug 23SellUS$23,733Kinnari PatelIndividual1,534US$15.47
20 Jul 23SellUS$10,906John MilitelloIndividual573US$19.03

내부자 거래량

내부자 구매: RCKT insiders는 지난 3개월 동안 주식만 판매했습니다.


소유권 분석

RCKT 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업105,9410.108%
개인 내부자2,306,7892.35%
헤지 펀드17,687,77218%
교육기관77,908,75579.5%

주식의 희석: 지난 해 주주 수는 희석되었으며, 총 발행 주식 수 12.8% 만큼 증가했습니다.


최대 주주

상위 25 주주가 회사의 84.42%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
19.5%
RTW Investments, LP
17,687,772US$368.8m0%6.23%
10.1%
Wellington Management Group LLP
9,156,099US$190.9m11.7%0.03%
6.53%
BlackRock, Inc.
5,929,910US$123.6m0%데이터 없음
5.92%
The Vanguard Group, Inc.
5,370,885US$112.0m-1.41%데이터 없음
4.62%
State Street Global Advisors, Inc.
4,193,077US$87.4m29.8%데이터 없음
4.39%
Westfield Capital Management Company, L.P.
3,984,030US$83.1m1.07%0.44%
4.28%
Maverick Capital, Ltd.
3,888,312US$81.1m-3.61%1.53%
3.24%
T. Rowe Price Group, Inc.
2,943,160US$61.4m12%0.01%
2.87%
Janus Henderson Group plc
2,606,016US$54.3m174%0.02%
2.72%
Citadel Advisors LLC
2,469,813US$51.5m0.5%0.05%
1.98%
Perceptive Advisors LLC
1,801,068US$37.6m5.49%0.81%
1.72%
Frazier Life Sciences Management, LP
1,561,230US$32.6m2.51%1.61%
1.66%
Geode Capital Management, LLC
1,502,587US$31.3m3.11%데이터 없음
1.61%
Tavistock Life Sciences
1,466,051US$30.6m0%1.67%
1.46%
Pictet Asset Management Limited
1,323,447US$27.6m-1.76%0.02%
1.43%
Logos Global Management, L.P.
1,300,000US$27.1m1.96%3.47%
1.39%
Avoro Capital Advisors LLC
1,260,900US$26.3m0%0.33%
1.25%
Gaurav Shah
1,134,307US$23.7m10.4%데이터 없음
1.23%
Franklin Resources, Inc.
1,117,141US$23.3m4.13%0.01%
1.21%
Cowen Inc,Private Banking and Investment Banking Investments
1,100,000US$22.9m0%0.71%
1.16%
Novo Holdings A/S
1,050,000US$21.9m0%0.01%
1.13%
Dimensional Fund Advisors LP
1,029,788US$21.5m-1.73%데이터 없음
1.13%
Avidity Partners Management, L.P.
1,025,000US$21.4m-40.4%0.87%
1.09%
Baron Capital Group, Inc.
990,544US$20.7m-5.89%0.05%
0.83%
Putnam LLC
750,093US$15.6m-29.9%0.02%